- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Rare case report of cyclosporine induced gingival hyperplasia
Suman Sethi and colleagues from the Department of Nephrology Dayanand Medical College and Hospital, Ludhiana, Punjab have recently studied an unusual case of cyclosporine induced gingival hyperplasia.
The study is published in the Journal of the Association of Physicians of India.
Drug-induced gingival overgrowth or enlargement manifests as abnormal growth of the gingiva due to an adverse drug reaction (ADR) in patients treated with anticonvulsants, immunosuppressants, and calcium channel blockers. As gingival enlargement develops, it affects the normal oral hygiene practice and may interfere with masticatory functions. It gradually becomes a source of pain and the condition often leads to disfiguration.
Researchers studied the case of a 28 year old male patient who was a known case of end stage renal disease on maintenance haemodialysis for last 1 year underwent live related renal transplant. The patient was on triple immunosuppression drugs (cyclosporine, MMF and glucocorticoids) for last 5 years and doing well on cyclosporine 75 mg twice daily, as the authors reported in their case report.
However, in the following years he presented with complaints of swelling of feet and breathlessness of 10 days duration. A thorough general clinical examination was carried out, suggestive of moderate pallor and pitting edema of feet.
Examination of oral cavity revealed significant gingival overgrowth in buccal mucosa of maxilla as well as mandible.
Furthermore, on lab evaluation his Hb was 8.8 g/dl, serum urea was 116 mg/dl and serum creatinine was 5.2 mg/dl. Serum cyclosporine level was 137 nmol/L (within therapeutic range). Renal graft biopsy was then done, suggestive of chronic allograft nephropathy.
Patient was not on medications like phenytoin or CCBs. The authors then made a final diagnosis of post renal transplant chronic allograft nephropathy with cyclosporine induced gingival hyperplasia.
Hence, the authors concluded that "gingival hyperplasia is a known complication of cyclosporine therapy and is more common in children and adolescents as compared to adults."
It can also be caused by drugs like phenytoin and CCBs. The degree of gingival hyperplasia is unrelated to the dose and levels of cyclosporine. Usually, the gingival overgrowth regresses after discontinuing the drug, they further added.
BDS, MDS( Pedodontics and Preventive Dentistry)
Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751